The Zhitong Finance App learned that Hygea Healthcare (06078) rose by more than 12%. As of press release, it had risen 12.41% to HK$10.6, with a turnover of HK$33.178 million.
According to the news, Hygea Healthcare announced its 2026 interim results, with revenue of 1.96 billion yuan for the first half of the year, down 1.4% year on year; net profit of 260 million yuan, up 4.7% year on year; adjusted net profit of 270 million yuan, up 1.5% year on year, up 38.1% month on month. The gross profit margin was 27.4%, and the adjusted net profit margin was 13.6%, all of which showed a steady recovery over the same period last year. The number of patients treated in the first half of the year was about 2.3 million, an increase of 4.1% over the previous year; the number of surgeries was about 46,000, an increase of 8.2% over the previous year, of which the number of grade 3 and 4 surgeries was about 21,000, an increase of 17.8% over the previous year.
According to the announcement, in December 2025, the company announced a share repurchase plan amounting to RMB 300 million. On the date of the announcement, it had implemented a share repurchase of 12.846,800 shares, accounting for about 2.08% of the total share capital. The total amount of capital used was about RMB 120 million. The share repurchase plan is still being implemented. In June of this year, the company further announced that the board of directors had approved a shareholder return plan. The company plans to use approximately RMB 500 million per year for the three fiscal years ending December 31, 2028 to provide returns to shareholders through share repurchases and/or dividends.